Jie Wu

Jie Wu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
LQLing Qiu
Ling Qiu
XCXin-Qi Cheng
Xin-Qi Cheng
JWJie Wu
Jie Wu
JLJun-Ting Liu
Jun-Ting Liu
TXTao Xu
Tao Xu
GZGuang-Jin Zhu
Guang-Jin Zhu
Hyperuricemia (HUA) is a potential risk factor for developing insulin resistance, hypertension, dyslipidemia and cardiovascular disease. Therefore, we studied the prevalence of HUA and associated risk factors in the population of two provinces in northern China. Based on the research of Chinese Physiological Constant and Health Conditions conducted in 2008–2010, we enrolled 29,639 subjects in a randomized, stratified study in four sampling areas in Heilongjiang Province and the Inner Mongolia Autonomous Region. We collected 13,140 serum samples to determine biochemical indicators including uric acid(UA), glucose, blood lipids, liver function, and renal function, and finally a representative sample of 8439 aged 18 years and older was determined. We also defined and stratified HUA, hypertension, diabetes, obesity and lipid abnormalities according to international guidelines. There were significant differences in the UA levels between different genders and regions. The total prevalence of HUA is 13.7%. Men had a higher prevalence of HUA than women (21% vs. 7.9%; P < 0.0001). As age increased, HUA prevalence decreased in men but rose in women. The suburbs of big cities had the highest HUA prevalence (18.7%), and in high-prevalence areas the proportion of women with HUA also increased. A stepwise logistic regression model was used to filter out twelve HUA risk factors, including age, gender, residence, hypercholesterolemia, hypertriglyceridemia, impaired fasting glucose, hypertension, obesity, abdominal obesity, CKD, drinking and sleeping. After adjusting for these factors, the odds ratio of HUA was 1.92 times higher in men than in women. Compared with agricultural and pastoral areas, the odds ratio of having HUA was 2.14 for participants in the suburbs of big cities and 1.57 in the center of big cities. The prevalence of HUA is high in northern China. The differences in HUA prevalence by geographic region suggested that unbalanced economic development and health education, therefore HUA prevention measures should be strengthened to improve quality of life and reduce health care costs.

1 September 2022 in Radiology
Verified
Journal Article
Closed access
YWYing Wei
Ying Wei
Wenquan NiuWenquan Niu
Wenquan Niu
ZZZhen-Long Zhao
Zhen-Long Zhao
JWJie Wu
Jie Wu
LPLi-Li Peng
Li-Li Peng
MYMing-An Yu
Ming-An Yu
In the treatment of T1N0M0 papillary thyroid carcinoma, the rates of disease progression and complications were not shown to be significantly different between microwave ablation and surgical resec... Background Microwave ablation (MWA) has attracted interest as a minimally invasive treatment for papillary thyroid carcinoma (PTC). However, comparisons between MWA and surgical resection (SR) in t...

1 April 2024 in Radiology
Verified
Journal Article
Closed access
ZZZhen-Long Zhao
Zhen-Long Zhao
SWShu-Rong Wang
Shu-Rong Wang
GDGang Dong
Gang Dong
YLYing Liu
Ying Liu
JHJun-Feng He
Jun-Feng He
MYMing-An Yu
Ming-An Yu
A 10-center study found no evidence of a significant difference in progression-free survival rate between microwave ablation (MWA) and surgical resection for US-detected multifocal T1N0M0 papillary thyroid carcinoma, with MWA resulting in fewer complications.

24 July 2019 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
DLDandan Li
Dandan Li
LZLiangrui Zhou
Liangrui Zhou
CMChaochao Ma
Chaochao Ma
WCWenhu Chen
Wenhu Chen
YZYimin Zhang
Yimin Zhang
LQLing Qiu
Ling Qiu
The serum lipid profile and clinical outcomes of cancer patients are commonly correlated in a wide range of carcinomas. However, few studies have investigated the serum lipid profile of patients with thyroid cancer (TC). The present study therefore aimed to analyze the lipid profiles of patients with TC. The serum proteomes of 31 participants with stage I‑IV TC were screened using Orbitrap Q Exactive Plus. Analytical data collected between November 1, 2013 and November 11, 2018 from the laboratory information system included the total cholesterol (CHO), triglyceride (TG), high‑density lipoprotein‑cholesterol (HDL‑C), low‑density lipoprotein cholesterol (LDL‑C), apolipoprotein A1 (ApoA1), lipoprotein (a) and apolipoprotein B (ApoB) levels that were used to validate the screening results. A total of 3875 outpatients were enrolled in this study. A number of 17 differentially expressed proteins were identified. An Ingenuity pathway analysis identified activation of the liver X receptor/retinoid X receptor (LXR/RXR) activation, which is a crucial pathway involved in lipid metabolism. The results demonstrated that the total CHO levels were significantly different between patients with TC and control groups, both in men and women. In women, the levels of TG, HDL‑C, Apo A1 and LDL‑C/HDL‑C were significantly different between patients with TC and control groups (all P<0.05). Higher concentrations of TG and LDL‑C/HDL‑C were observed in the cancer group compared with the control group. However, lower levels of Apo A1 and HDL‑C were observed in women from the cancer group compared with the control group. The results from the present study revealed the presence of a disordered lipid profile in patients with TC. The molecular mechanism underlying the association between lipid metabolism and cancer requires further investigation and may be used to develop novel diagnostic biomarkers and therapeutic targets in human cancers.

1 January 2024 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
YFYu-Lin Fei
Yu-Lin Fei
YWYing Wei
Ying Wei
ZZZhen-Long Zhao
Zhen-Long Zhao
LPLi-Li Peng
Li-Li Peng
YLYan Li
Yan Li
MYMing-An Yu
Ming-An Yu
Fei YL, et al. Korean J Radiol. 2024 Aug;25(8):756-766. https://doi.org/10.3348/kjr.2023.1279

12 October 2011 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JWJie Wu
Jie Wu
WYWen-Hua Yan
Wen-Hua Yan
LQLing Qiu
Ling Qiu
XCXin-Qi Chen
Xin-Qi Chen
XGXiu-Zhi Guo
Xiu-Zhi Guo
GZGuang-Jin Zhu
Guang-Jin Zhu
Background: Prehypertension and prediabetes are major risk factors of cardiovascular disease, and their combined presence may result in more serious cardiovascular outcomes than expected with either prehypertension or prediabetes alone. The aim of the present study was to evaluate the prevalence of coexisting prehypertension and prediabetes, and the associated risk profiles in a Chinese population. Methods: A cross-sectional survey in a representative sample of 3,595 men and 4,593 women aged 18 years and older was performed between 2008 and 2010. Prehypertension and prediabetes were diagnosed using the guidelines from the Seventh Report of the Joint National Committee on prevention, detection, and treatment of high blood pressure and American Diabetes Association, respectively. Prehypertension was defined as a systolic blood pressure of 120-139 mmHg and/or diastolic blood pressure of 80-89 mmHg, and prediabetes was defined as a fasting blood glucose of 5.6-6.9 mmol/L. Results: The prevalence of coexisting prehypertension and prediabetes was 11.0%. Men had a higher prevalence of coexisting prehypertension and prediabetes than women (14.2% vs. 8.4%; P < 0.0001). This prevalence increased with age and body mass index, and was the lowest among Mongolian-Chinese (5.1%). A multivariate analysis showed that γ-glutamyltransferase and uric acid were significantly and positively correlated with body mass index, waist circumference, blood pressure, triglycerides, and total cholesterol, and negatively correlated with high density lipoprotein cholesterol in subjects with prehypertension and prediabetes. Conclusions: There is a large proportion of Chinese adults with coexisting prehypertension and prediabetes. Thus, there is a need for more efforts that implement public health programs that target the earlier stages of hypertension and diabetes.